Clinical Trial Update: Safety and Efficacy of Iontophoretic Dexamethasone Phosphate Delivery Prior to Implantation of a Posterior Chamber IOL [Phase 2]

View source ↗

Summary

Phase 2 trial assessed safety and efficacy of iontophoretic dexamethasone phosphate delivered before posterior chamber IOL implantation in cataract patients; st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cataract

Drugs mentioned

• Dexamethasone phosphate iontophoretic delivery (dexamethasone phosphate)

Snippet

Sponsor: Eyegate Pharmaceuticals, Inc. | Conditions: Cataract | Phase 2 | Status: COMPLETED | Results posted: 2018-05-21